These pathways are associated with diabetic cardiomyopathy, platelet activation, insulin resistance, thyroxine release, and signaling pathways such as the PI3K-AKT, cAMP, and peroxisome proliferator-activated receptor (PPAR) pathways. Here, AKT1 is linked to Insulin resistance.